LQDA [NASD]
Liquidia Corporation
Index- P/E- EPS (ttm)-0.79 Insider Own8.50% Shs Outstand52.47M Perf Week36.20%
Market Cap374.96M Forward P/E- EPS next Y-0.50 Insider Trans145.25% Shs Float48.86M Perf Month99.73%
Income-41.30M PEG- EPS next Q-0.21 Inst Own41.70% Short Float4.18% Perf Quarter31.39%
Sales13.30M P/S28.19 EPS this Y60.50% Inst Trans13.75% Short Ratio1.09 Perf Half Y24.17%
Book/sh1.06 P/B7.03 EPS next Y46.90% ROA-42.20% Target Price12.71 Perf Year185.44%
Cash/sh1.15 P/C6.49 EPS next 5Y- ROE-60.60% 52W Range2.40 - 8.79 Perf YTD52.98%
Dividend- P/FCF- EPS past 5Y7.20% ROI-44.20% 52W High-15.24% Beta0.34
Dividend %- Quick Ratio7.80 Sales past 5Y-0.60% Gross Margin77.20% 52W Low210.42% ATR0.72
Employees47 Current Ratio7.80 Sales Q/Q12.90% Oper. Margin- RSI (14)69.76 Volatility21.18% 14.05%
OptionableYes Debt/Eq0.36 EPS Q/Q-43.80% Profit Margin- Rel Volume1.48 Prev Close8.39
ShortableYes LT Debt/Eq0.36 EarningsAug 11 BMO Payout- Avg Volume1.88M Price7.45
Recom1.60 SMA2035.13% SMA5055.83% SMA20040.67% Volume2,784,818 Change-11.20%
Jul-22-22Initiated Ladenburg Thalmann Buy $15
May-31-22Initiated BTIG Research Buy $14
May-26-22Initiated BofA Securities Buy $12
Dec-04-20Initiated H.C. Wainwright Buy $6
Nov-20-20Downgrade Wedbush Outperform → Neutral $20 → $4
Nov-08-18Resumed Jefferies Buy
Sep-05-18Initiated Wedbush Outperform $26
Aug-20-18Initiated Needham Buy $30
Aug-20-18Initiated Jefferies Buy $22
Aug-15-22 05:59PM  
09:55AM  
Aug-13-22 08:13AM  
Aug-11-22 07:55AM  
06:45AM  
Aug-04-22 08:18AM  
Aug-01-22 07:35PM  
07:46AM  
06:24AM  
Jul-25-22 08:51AM  
08:27AM  
Jul-21-22 04:30PM  
Jul-19-22 04:30PM  
Jul-14-22 10:28AM  
Jun-27-22 06:26AM  
Jun-24-22 04:15PM  
09:35AM  
Jun-20-22 07:00AM  
Jun-14-22 09:43AM  
Jun-09-22 04:30PM  
Jun-07-22 04:30PM  
Jun-02-22 09:04AM  
May-26-22 04:34PM  
May-25-22 10:16AM  
May-24-22 03:02PM  
May-16-22 07:30AM  
May-15-22 08:38AM  
May-12-22 08:15AM  
07:00AM  
May-10-22 08:15AM  
May-05-22 09:05AM  
08:00AM  
Apr-27-22 06:31AM  
Apr-25-22 08:45AM  
Apr-22-22 06:18AM  
Apr-20-22 10:01AM  
Apr-18-22 04:05PM  
Apr-13-22 03:04PM  
Apr-12-22 09:38PM  
04:53PM  
04:17PM  
Apr-01-22 03:57PM  
05:13AM  
Mar-22-22 04:30PM  
Mar-17-22 07:45AM  
06:30AM  
Mar-10-22 09:40AM  
07:00AM  
Mar-03-22 07:34AM  
Mar-01-22 06:22AM  
Feb-23-22 06:30AM  
Feb-15-22 12:20PM  
Jan-10-22 07:45AM  
Jan-07-22 09:02AM  
Jan-06-22 03:11PM  
Jan-03-22 04:52PM  
12:43PM  
Dec-29-21 06:45AM  
Nov-26-21 06:00AM  
Nov-11-21 04:30PM  
11:50AM  
08:52AM  
Nov-10-21 02:59PM  
Nov-08-21 10:11AM  
05:45AM  
Nov-03-21 07:05PM  
04:55PM  
Oct-12-21 08:38AM  
Oct-08-21 05:23PM  
Sep-10-21 08:29AM  
Aug-27-21 09:43AM  
Aug-18-21 04:15PM  
Aug-12-21 08:00AM  
Aug-10-21 08:15AM  
07:00AM  
Aug-03-21 07:00AM  
Jul-13-21 07:12AM  
Jun-07-21 06:00AM  
Jun-02-21 07:00AM  
May-26-21 07:00AM  
May-24-21 04:05PM  
May-13-21 12:11PM  
07:00AM  
06:30AM  
May-10-21 06:30AM  
May-06-21 07:00AM  
Apr-29-21 06:03AM  
Apr-19-21 11:47AM  
Apr-13-21 07:00AM  
Apr-07-21 07:00AM  
Mar-30-21 07:00AM  
Mar-23-21 07:00AM  
06:30AM  
Mar-15-21 04:02AM  
Mar-09-21 07:30AM  
Mar-02-21 08:30AM  
Jan-04-21 03:11PM  
11:00AM  
Dec-31-20 04:21PM  
12:47PM  
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaseta MichaelChief Financial OfficerMay 31Buy4.0118,70074,93627,950Jun 01 05:50 PM
Caligan Partners LPDirectorMay 25Buy3.4079,400269,96010,393,627May 26 08:47 AM
Lippe Robert AChief Operations OfficerMay 24Buy3.3829,62899,99790,692May 25 07:28 PM
JEFFS ROGERChief Executive OfficerMay 24Buy3.5328,00098,81246,595May 25 07:27 PM
Caligan Partners LPDirectorMay 19Buy5.8185,000493,85010,314,227May 19 06:16 PM
Caligan Partners LPDirectorMay 18Buy5.8976,404450,02010,229,227May 19 06:16 PM
Caligan Partners LPDirectorMay 17Buy5.9959,700357,60310,152,823May 19 06:16 PM
Caligan Partners LPDirectorApr 18Buy5.101,764,7058,999,99610,093,123Apr 18 06:29 PM
Manning Paul BDirectorApr 18Buy5.10392,1561,999,996392,156Apr 19 04:30 PM
Schundler RussellGeneral CounselNov 10Buy4.21117,908496,834220,588Nov 10 06:01 PM
Kirsch Arthur SDirectorNov 10Buy4.2430,000127,20032,000Nov 12 04:16 PM